According to independent agencies, following the results of 9 months of 2025, sales of Ozon Pharmaceuticals to end customers (Sell-Out) in monetary terms in the retail segment increased by 25-38% year-on-year, which is 2-3 times higher than the market dynamics. In Sell-out packages, the company's sales are also growing at double-digit rates, while the market as a whole is declining. Sell Out indicator can be very different from the manufacturer's shipments, which determine the amount of revenue. The company will disclose operational and financial data on November 25.